Steps in the management of psoriatic arthritis: a guide for clinicians.

about

Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNFα in psoriatic arthritis.Secukinumab: a promising therapeutic option in spondyloarthritis.

P2860

Q34414970-98F54168-C451-4471-8B23-DB1379B3F639 Q38903129-0F98C425-1FDA-4F35-8901-29844BECB91A

P2860

Steps in the management of psoriatic arthritis: a guide for clinicians.

Item

http://www.wikidata.org/entity/Q36515480

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Steps in the management of psoriatic arthritis: a guide for clinicians.

@ast

Steps in the management of psoriatic arthritis: a guide for clinicians.

@en

type

Item

label

Steps in the management of psoriatic arthritis: a guide for clinicians.

@ast

Steps in the management of psoriatic arthritis: a guide for clinicians.

@en

prefLabel

Steps in the management of psoriatic arthritis: a guide for clinicians.

@ast

Steps in the management of psoriatic arthritis: a guide for clinicians.

@en

P1476

Steps in the management of psoriatic arthritis: a guide for clinicians.

@en

P2093

Ignacio Garcia-Valladares

http://www.w3.org/2001/XMLSchema#string

Luis R Espinoza

http://www.w3.org/2001/XMLSchema#string

Raquel Cuchacovich

http://www.w3.org/2001/XMLSchema#string

Rodolfo Perez-Alamino

http://www.w3.org/2001/XMLSchema#string

P2860

Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthriti

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

Infliximab: 12 years of experience

Newly available treatments for psoriatic arthritis and their impact on skin psoriasis.

Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study.

TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

A randomized placebo-controlled trial of methotrexate in psoriatic arthritis

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis.

P304

259-269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2040622312459673

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23342240

http://www.w3.org/2001/XMLSchema#string

P932

3539260

http://www.w3.org/2001/XMLSchema#string

Steps in the management of psoriatic arthritis: a guide for clinicians.

about

P2860

P2860

Steps in the management of psoriatic arthritis: a guide for clinicians.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932